« Back to Record
Berghmans, T., Remmelink, M., & Awada, A. (2012). Anaplastic lymphoma kinase (ALK) inhibitors for second line therapy of Non-Small Cell Lung Cancer. Lung cancer (Auckland), 3, 91-99.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/141403



